Bayer raises 2026 profit outlook on strong pharmaceuticals performance
Economic Times
Bayer raised its 2026 profit outlook after its pharmaceuticals division
delivered stronger-than-expected third-quarter sales. The German group also
lowered its debt forecast, signalling improving growth momentum and a stronger
financial position.

